Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics
Australia’s New South Wales has moved to end the automatic penalisation of medicinal cannabis patients caught driving with THC in
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the
Last week (April 27), the deadline for Greek industry stakeholders to have their say on a controversial new hemp ban
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks. Organigram has closed its
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times,
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on
Cannabis remained Europe’s most commonly used drug in 2025, according to new wastewater analysis from the European Union Drugs Agency
US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all
The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the
California Governor Gavin Newsom has vetoed legislation that would have allowed certain cannabis microbusinesses to ship medical products directly to
At a Glance Date: Thursday, 6 November 2025 Venue: The Wythe Hotel, Williamsburg, New York Attendees: 200+ industry leaders, investors,
First published on Cannabis Health In a landmark decision, Spain’s Council of Ministers has approved a Royal Decree regulating the
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in
We won’t spam you
